Independent verification guide

Licensed Ibogaine Clinic: A Verification Checklist

“Legal,” “licensed,” “medical,” and “safe” are different claims. People researching ibogaine should ask a clinic to prove each one separately, before payment or travel.

This resource does not recommend treatment or replace medical or legal advice. It is a practical framework for asking clear questions about ibogaine safety, licensing, monitoring, consent, and continuity of care.

Calm clinical setting representing careful ibogaine treatment verification

Verify the system,
not the marketing.

Start with the distinction

A clinic can be legal without being prepared.

A licensed ibogaine clinic is not a universally recognized legal category. A treatment facility may hold a business, medical, pharmacy, or facility license without being specifically authorized to provide ibogaine treatment. Verification must cover the jurisdiction, substance, clinician, facility, protocol, and emergency system.

Ask for the clinic’s legal entity, operational permit, and the authority that issued it.
Ask who is the medical director, whether a physician is continuously on site, and how medical credentials are verified.
Ask for written medical screening, pre-treatment testing, medication washout, and contraindications criteria.
Ask how continuous monitoring, emergency transfer, aftercare, and integration are handled in practice.

Detail representing documentation and careful clinical verification

Medical screening and pre-treatment evaluations

Screen first. Dose decisions come later.

Medical screening is the foundation of patient safety. A credible clinic should explain its intake protocol before discussing dosage or a flood dose. The process should include medical history, medication review, physical assessment, psychiatric evaluation, and medical clearance by qualified medical personnel.

Pre-treatment testing should include a complete blood count, comprehensive metabolic panel, hepatic function tests, renal function evaluation, and a liver panel. It should also document electrolyte levels, especially potassium and magnesium, because low potassium and magnesium can materially increase cardiac risk.

A toxicology screen immediately on admission helps identify contraindicated substances, including stimulants, sedatives, non-prescribed opioids, fentanyl, and other drugs that can complicate opioid withdrawal. A clinic should be able to explain how test results affect postponement, referral, or exclusion.

Psychiatric evaluation is not a formality. Medical staff should screen for active psychosis and personal or family histories of schizophrenia or bipolar I disorder. Mental health history, current symptoms, and psychological support needs should shape whether a person is screened out or referred for a different level of care.

International regulatory frameworks and local permits

Verify legal status by destination, not by a website label.

Mexico is often discussed in ibogaine research and patient forums, but Mexico does not offer a single universal “ibogaine clinic license.” A facility describing itself as medical should be prepared to identify its permits and its relationship to COFEPRIS, Mexico’s federal sanitary-risk authority. Ask which authorization applies to the treatment facility, product handling, and physician practice.

New Zealand uses a different framework: ibogaine is described as a non-approved prescription medicine that may be prescribed and administered by registered medical doctors under strict oversight. In the Bahamas and other destinations, regulations and enforcement can differ by island, facility, and service offered.

Independent verification means contacting the named regulator, medical board, or licensing body directly. Ask for license numbers, names exactly as registered, issue dates, and whether there are restrictions. Do not accept a logo, a testimonial, or vague language as clinical accreditation.

The admissions checklist published by New Roots can help frame questions, but a prospective patient still needs confirmation from the relevant jurisdiction. Legal status, clinical accreditation, and patient safety are separate questions.

Cardiac safety and continuous ecg monitoring standards

Cardiac risk requires a visible, staffed system.

Ibogaine blocks hERG potassium channels in cardiac tissue, delaying ventricular repolarization and contributing to QT prolongation. hERG channels are central to the electrical timing of the heart; the clinical meaning of long QT risk is why a casual pulse check is not an adequate safety plan.

A baseline 12-lead ECG should be performed before administration. The stated threshold in a written protocol should confirm a resting QTc below 450 milliseconds for men and 460 milliseconds for women. A prior abnormal ECG, arrhythmias, or a concerning history should trigger physician review rather than a quick reassurance.

Continuous ECG monitoring through real-time telemetry should begin with dosing and continue through the acute phase, typically 24 to 36 hours. Continuous monitoring should include ECG monitoring, pulse oximetry, blood pressure, oxygen status, hydration, and repeated vital signs. Ask whether a holter monitor is used before arrival when indicated, and who reads the tracing.

Severe electrolyte imbalances make torsades de pointes more likely. A clinic should document electrolyte levels and correct low potassium and magnesium before a flood dose. It should also explain its emergency protocol for QT prolongation, arrhythmias, and cardiac instability.

Local proof is operational proof

Look for answers that are specific enough to verify.

“Who is the on-site physician during the high-risk period?”

A legitimate answer names the role, license jurisdiction, coverage schedule, and escalation chain.

“Which hospital receives an emergency transfer?”

A written emergency protocol should identify a fully equipped acute-care destination and practical transit time.

“Can I see the testing and consent documents before travel?”

Clear, advance documentation is more useful than broad safety assurances after a deposit is paid.

Physician qualifications and medical staff licensing

Names, licenses, supervision, and staffing ratios matter.

A verified clinic should operate under continuous on-site supervision of a licensed physician who is ACLS certified. Ask whether the physician is credentialed in the jurisdiction, how their medical credentials can be verified, and whether they are physically present through the acute treatment period.

Medical staff should include a registered nurse or other qualified medical personnel with a clearly defined role in continuous monitoring, intravenous access, vital signs, hydration, medication response, and documentation. A safe clinical operation should maintain at least one registered medical professional for every two patients throughout acute treatment.

Ask whether the physician, registered nurse, and other medical staff are ACLS certified, when certification was renewed, and who handles a deterioration during the night. “On call” is not the same as on site. A clinic should state its staffing ratios without hesitation.

Prospective patients can compare broad questions against the clinic-selection questions outlined by Mindscape Retreat, while keeping independent license verification as the central step.

Emergency transport protocols and hospital proximity

A defibrillator is not an emergency system by itself.

Treatment rooms should have a dedicated automated external defibrillator or manual defibrillator, emergency oxygen, suction machines, bag-valve masks, resuscitation equipment, and intravenous access established before treatment. These items matter only when trained medical staff can use them immediately.

A credible emergency protocol should specify the first response to torsades de pointes, severe QT prolongation, blood pressure instability, changing vital signs, or other arrhythmias. It should include who calls emergency services, who stays with the patient, and how records accompany an emergency transfer.

Hospital proximity is practical rather than promotional. A verified clinic should hold a written, legally binding emergency transfer agreement with a fully equipped acute-care hospital within a 15-to-30-minute transit window. Ask to see the agreement or at least confirm the named hospital’s role directly.

“Intensive care available nearby” is too vague. Ask whether the hospital can manage cardiac emergencies, whether the route has been tested, and whether emergency services know the treatment facility. Emergency transfer plans should account for location, border crossings, weather, and local transport realities.

The facility questions collected by Holistic Sanctuary are a useful prompt, but do not substitute for direct confirmation of equipment, physician coverage, and emergency transfer arrangements.

Patient advocacy starts with documents. Keep copies of the intake protocol, informed consent, medical clearance findings, ECG results, medication list, and emergency contact information before departure.

Medication tapering and contraindication management

Medication timing cannot be treated as a travel detail.

Long-acting opioids deserve particular caution. Prior exposure to methadone or buprenorphine may require complete tapering and stabilization on short-acting opioids for several weeks before ibogaine therapy. A clinic should not tell someone to stop medication abruptly without a physician-led plan.

Fentanyl, methadone, buprenorphine, alcohol, sedatives, stimulants, antidepressants, and cardiac medications can all change the risk picture. Contraindications should be written, individualized, and connected to medical screening, lab testing, ECG monitoring, and a medication reconciliation process.

The comparison of ibogaine and methadone should not be used as a reason to self-manage a taper. Opioid withdrawal and addiction treatment require a clinician who can assess the person, the medication, timing, and medical risk.

Ibogaine sourcing purity and laboratory testing

Ask what the product is, where it came from, and how it was tested.

Reputable centers should be able to identify the product, concentration, batch, storage conditions, dosage approach, and chain of custody. Standardized ibogaine hydrochloride should be supported by independent third-party lab testing, including mass spectrometry and high-performance liquid chromatography, to confirm alkaloid purity.

Ask for a certificate of analysis that corresponds to the batch used. A general claim that a product is “pure” is not the same as evidence of alkaloid purity. The clinic should also explain whether it uses ibogaine hydrochloride, how it addresses noribogaine exposure, and how physician oversight informs dosing decisions.

The selection guidance from Experience Ibogaine highlights why product questions belong beside staff and emergency questions. No single item establishes safety; the system has to work together.

Psychological preparation and post-treatment integration

Aftercare is part of the safety checklist.

Ibogaine screening should not stop at laboratory values and ECG monitoring. Psychological support before treatment, during observation, and after discharge matters. A clinic should explain how it assesses mental health, supports informed consent, and responds to distress after the acute experience.

Integration should have a defined plan, not a generic promise. Ask who provides aftercare, how long follow-up lasts, whether there is a crisis pathway, and how the clinic coordinates with a person’s existing addiction treatment or mental health provider when appropriate.

Our approach to independent ibogaine information is grounded in plain language and questions people can verify. The broader research tools and practical guides on this site are informational only; they do not screen candidates or provide medical clearance.

For a second set of practical prompts, review the transparency checklist from Casa Santa Isabel and compare every answer with the clinic’s own written policies.

Critical red flags when evaluating an ibogaine facility

When answers stay vague, pause the process.

Marketing over medical evidence

Be cautious when a provider makes guaranteed addiction treatment claims, minimizes opioid withdrawal, or presents ibogaine as proven safe for everyone. The U.S. Food and Drug Administration states that ibogaine has not received FDA approval for treatment.

No continuous ECG monitoring

Intermittent checks, consumer wearables, or verbal assurances are not a substitute for continuous cardiac monitoring during a flood dose and the acute phase.

Unclear clinician presence

Red flags include unnamed physicians, unverifiable medical credentials, no ACLS certified coverage, or a claim that a remote physician is enough for all emergencies.

No transfer agreement

Underground clinics may rely on improvised transport or vague hospital proximity. A credible treatment facility can describe its emergency protocol, resuscitation equipment, emergency services access, and emergency transfer route.

Keep the threshold high. The ibogaine clinic checklist for prospective patients can help organize notes, but no checklist can turn a poor answer into a safe one. Repeated pressure to pay quickly, hide medication use, or bypass medical screening is reason to step away.

Step-by-step verification process for prospective patients

Use a record-based process before committing.

Identify the legal entity

Request the clinic’s registered name, facility address, local permits, medical director, and the regulator that can confirm each record.
Confirm clinician licensing

Verify the physician and medical staff through the relevant licensing body. Confirm ACLS certified coverage, registered nurse availability, and 24-hour observation practices.
Review the safety checklist

Ask for medical screening, pre-treatment testing, liver panel, electrolyte levels, ECG monitoring, toxicology screen, psychiatric evaluation, contraindications, and medication tapering rules.
Inspect emergency readiness

Confirm defibrillator access, oxygen, suction, bag-valve masks, intravenous access, resuscitation equipment, hospital proximity, and a written emergency transfer agreement.
Read consent and aftercare plans

Review informed consent, psychological support, integration, aftercare, patient advocacy routes, complaints procedures, and post-treatment emergency contacts.

Practical questions

Frequently asked questions

What medical tests are mandatory before undergoing ibogaine treatment?

A safety-focused review should include medical history, physical assessment, baseline 12-lead ECG, complete blood count, comprehensive metabolic panel, hepatic and renal function review, a liver panel, electrolyte levels, toxicology screen, and psychiatric evaluation. Potassium and magnesium deserve particular attention. The treating physician must determine what is appropriate for an individual person.

How can patients independently verify the license of an international ibogaine clinic?

Ask for the registered legal name, facility permit, physician license number, medical director, and issuing authority. Then contact that regulator or licensing body directly. In Mexico, ask what permits apply and whether COFEPRIS records support the clinic’s claims. In New Zealand, confirm the registered physician and the oversight route. A website statement alone is not verification.

Why is continuous cardiac monitoring necessary during an ibogaine flood dose?

Ibogaine can affect hERG channels, cause QT prolongation, and increase the risk of arrhythmias including torsades de pointes. Real-time continuous ECG monitoring through telemetry helps qualified medical personnel detect changing cardiac rhythm during the acute phase. Vital signs, pulse oximetry, blood pressure, hydration, and oxygen status should also be observed.

What emergency medical equipment and certifications must an ibogaine clinic maintain on site?

Ask about a defibrillator, emergency oxygen, suction, bag-valve masks, resuscitation equipment, intravenous access, cardiac medications, and a written emergency protocol. Confirm that a licensed physician and medical staff are ACLS certified, that staffing ratios support continuous monitoring, and that a formal emergency transfer agreement exists with an acute-care hospital.

What are the warning signs of an unsafe or unregulated ibogaine provider?

Key red flags include absent or vague medical screening, no baseline ECG, no continuous ECG monitoring, unclear physician presence, unverifiable medical credentials, no written contraindications, product claims without lab testing, no hospital proximity plan, rushed consent, and no aftercare or integration process. Underground clinics may use reassuring language while avoiding documents that can be independently verified.

For additional context on comparing treatment-center claims, the overview of ibogaine treatment centers by HealingMaps may help generate questions. Use it as a starting point, not a substitute for verification, medical clearance, or local legal advice.

Before you travel or pay

Keep the questions. Request the documents. Verify the answers.

Licensed Ibogaine Clinic is an independent resource for people researching ibogaine, with a focus on evidence, safety, legality, and practical questions.

Explore ibogaine research context

For further context, see www.experienceibogaine.com/choosing-the-right-ibogaine-clinic.